years ago. Cli was a waste of money and a total distraction. That patient population is beyond hope and any margional gains will be quickly lost. Cli patients are least likely to actively work on rehabilitating themselves and change their lifestyles, which got em in trouble in the first place.
DCM is a totally different animal and if the stem cells work as suggested in early trials, can add meaningful quality of life years to patients that have few options. Get on with it already.
And who decided 70 cents was the right re-price for this. Good riddence if you sold; after seeing focus on DCM I bought more. Thanks for the cheap shares.
Most are obesity and diabetes related which are lifestyle choices. Proper care of diabetes is possible but again it is a choice. When you get to the point of CLI, you've made many bad choices and are not likely to rehabilitate yourself to where the stem cells are going to give significant benefit.
No judgement, also no PC attitude, just the facts. You may stick your PC attitude where the sun don't shine. I hope I haven't hurt your feelings.